Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation.

Transplantation

Department of Cardiology, Northwell Health, Zucker School of Medicine at Hofstra, Northwell, North Shore University Hospital, Manhasset, NY.

Published: December 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664776PMC
http://dx.doi.org/10.1097/TP.0000000000004843DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor immunogenicity
4
immunogenicity third
4
third dose
4
dose covid-19
4
covid-19 vaccine
4
vaccine cardiac
4
cardiac transplantation
4
letter
1
immunogenicity
1

Similar Publications

Background: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, most but not all randomized trials have reported that complete revascularization (CR) offers advantages over culprit vessel-only revascularization. In addition, the optimal timing and assessment methods for CR remain undetermined.

Objectives: The purpose of this study was to identify the optimal revascularization strategy in patients with STEMI and multivessel disease, using a network meta-analysis of randomized controlled trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!